PAPPALARDO, FEDERICO
 Distribuzione geografica
Continente #
AS - Asia 3.693
NA - Nord America 1.819
EU - Europa 1.573
SA - Sud America 1.151
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 8.301
Nazione #
US - Stati Uniti d'America 1.728
SG - Singapore 1.612
CN - Cina 1.035
BR - Brasile 989
SE - Svezia 639
HK - Hong Kong 515
IT - Italia 294
VN - Vietnam 279
RU - Federazione Russa 220
DE - Germania 116
AR - Argentina 66
IN - India 65
FI - Finlandia 63
GB - Regno Unito 57
CA - Canada 44
BD - Bangladesh 42
AT - Austria 35
EC - Ecuador 35
FR - Francia 30
IE - Irlanda 30
ID - Indonesia 24
PL - Polonia 21
CO - Colombia 19
MX - Messico 19
IQ - Iraq 17
PY - Paraguay 17
ZA - Sudafrica 16
ES - Italia 15
TR - Turchia 15
PK - Pakistan 12
UA - Ucraina 12
JP - Giappone 11
NL - Olanda 11
KE - Kenya 9
VE - Venezuela 9
MA - Marocco 8
UZ - Uzbekistan 8
CH - Svizzera 7
CL - Cile 6
DO - Repubblica Dominicana 6
EG - Egitto 6
HN - Honduras 6
TN - Tunisia 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
JO - Giordania 5
OM - Oman 5
SA - Arabia Saudita 5
GT - Guatemala 4
IL - Israele 4
KG - Kirghizistan 4
KW - Kuwait 4
AU - Australia 3
DZ - Algeria 3
EU - Europa 3
JM - Giamaica 3
KR - Corea 3
LT - Lituania 3
MD - Moldavia 3
MY - Malesia 3
PE - Perù 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
AL - Albania 2
AM - Armenia 2
BE - Belgio 2
EE - Estonia 2
IR - Iran 2
MN - Mongolia 2
NI - Nicaragua 2
NP - Nepal 2
AI - Anguilla 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
ET - Etiopia 1
HR - Croazia 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
ML - Mali 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
Totale 8.298
Città #
Singapore 599
Hong Kong 515
Dallas 353
Shanghai 284
Hefei 234
Princeton 225
Lawrence 224
Ashburn 185
Beijing 129
Ho Chi Minh City 96
Milan 92
New York 89
Moscow 84
São Paulo 83
Hanoi 59
Helsinki 54
Los Angeles 53
Nuremberg 39
Rio de Janeiro 34
Rome 32
Dublin 29
Boardman 25
Vienna 22
The Dalles 20
Montreal 19
Warsaw 19
Brasília 17
Haiphong 17
Belo Horizonte 16
Curitiba 16
Atlanta 15
Turin 15
Brooklyn 14
Chennai 14
Pune 14
Quito 14
Columbus 13
Porto Alegre 13
Stockholm 13
Campinas 12
Da Nang 12
Munich 12
Orem 12
Phoenix 12
Tokyo 11
Boston 10
Denver 10
Guangzhou 10
Mapello 10
Salvador 10
Thái Bình 10
Fortaleza 9
Guarulhos 9
Houston 9
London 9
Poplar 9
San Francisco 9
Santa Clara 9
Uberlândia 9
Xi'an 9
Chicago 8
Guayaquil 8
Manchester 8
Santo André 8
Ankara 7
Asunción 7
Bauru 7
Bogotá 7
Cesano Boscone 7
Johannesburg 7
Magé 7
Nairobi 7
Shenzhen 7
Shijiazhuang 7
Tashkent 7
Tianjin 7
Toronto 7
Turku 7
Wuxi 7
Biên Hòa 6
Calgary 6
Contagem 6
Falkenstein 6
Franca 6
Hangzhou 6
Maceió 6
Mexico City 6
Nova Iguaçu 6
Parma 6
Reston 6
São José dos Campos 6
Volta Redonda 6
Amman 5
Ancona 5
Aracaju 5
Bengaluru 5
Bologna 5
Canoas 5
Caxias do Sul 5
Changsha 5
Totale 4.255
Nome #
470 MYOCARDIAL FIBROSIS IN ASYMPTOMATIC PATIENTS UNDERGOING SURGERY FOR MITRAL AND AORTIC VALVE REGURGITATION 149
A meta-analysis of complications and mortality of extracorporeal membrane oxygenation 107
Afterload mismatch after MitraClip insertion for functional mitral regurgitation 95
Abdominal Compartment Syndrome During Extracorporeal Membrane Oxygenation 74
A new phosphorylcholine-coated polymethylpentene oxygenator for extracorporeal membrane oxygenation: a preliminary experience 64
Optimal versus suboptimal mitral valve repair: late results in a matched cohort study 64
Acute right ventricular failure post ascending aorta surgery 62
Different anesthesiological management in two high risk pregnant women with heart failure undergoing emergency cesarean section 60
Anticoagulation management in patients undergoing open heart surgery by activated clotting time and whole blood heparin concentration 58
2012 pandemic flu 58
An unusual cause of cardiogenic shock: tricuspid regurgitation and right ventricular perforation due to vena cava filter migration 58
EARLY DIAGNOSIS OF PUMP THROMBOSIS BASED ON TIME-FREQUENCY ANALYSIS OF LOG-FILES OF THE HEARTWARE HVAD VENTRICULAR ASSIST DEVICE 56
Adjunctive therapies during veno-venous extracorporeal membrane oxygenation 56
Acute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation 56
A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury 55
An Unusual "Swinging" Biatrial Mass 54
Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices 54
Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study 54
Bleeding in patients with continuous-flow left ventricular assist devices: acquired von Willebrand disease or antithrombotics? 53
Aortic Cannula Disruption Following Long-Term LVAD Support. 51
Anticoagulation for Critically Ill Cardiac Surgery Patients: Is Primary Bivalirudin the Next Step? 51
Venoarterial Extracorporeal Membrane Oxygenation for Acute Fulminant Myocarditis in Adult Patients: A 5-Year Multi-Institutional Experience 51
Human protein C concentrate in pediatric septic patients 50
Anesthetic management of transcatheter aortic valve implantation with transaxillary approach. 50
Blood Purification With CytoSorb in Critically Ill Patients: Single-Center Preliminary Experience 50
2019 EACTS Expert Consensus on long-term mechanical circulatory support 50
Analysis Of The Effect Of Component Elements Of Hemodynamic Shear Stress Profiles On Shear-Mediated Platelet Activation In Cardiovascular Implantable Therapeutic Devices 49
Veno-venous extracorporeal membrane oxygenation in the surgical management of post-traumatic intrathoracic tracheal transection 49
Inflow cannula obstruction of the HeartWare left ventricular assist device: what do we really know? 48
Mechanical chest compression and extracorporeal life support for out-of-hospital cardiac arrest. A 30-month observational study in the metropolitan area of Milan, Italy 47
Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. 47
High Frequency Components of Hemodynamic Shear Stress Profiles are a Major Determinant of Shear-Mediated Platelet Activation in Therapeutic Blood Recirculating Devices. 47
First in man prolonged pressure-controlled intermittent coronary sinus occlusion to treat refractory left ventricular dysfunction and ischemia with patent epicardial coronary arteries 47
ECG changes after CABG: the role of the surgical technique 46
Log Files of Continuous-Flow Left Ventricular Assist Devices Reveal Diurnal Changes of Pump Parameters Beyond Circadian Variations 46
Performing chronic hemodialysis therapy in a patient with total artificial heart. 45
Can we predict the thrombotic risk in patients with left ventricular assist devices? 45
Weaning from veno-venous extracorporeal membrane oxygenation: How I do it 45
The extracorporeal life support organization Maastricht treaty for nomenclature in extracorporeal life support a position paper of the extracorporeal life support organization 45
Myocardial necrosis biomarkers after different cardiac surgical operations 44
Beating-heart coronary artery bypass graft surgery at San Raffaele Hospital: four years of experience 44
A narrative review of the technical standards for extracorporeal life support devices (pumps and oxygenators) in Europe 44
COMPARATIVE ANALYSIS OF THE THROMBOGENIC POTENTIAL OF THE HEARTMATE 3 AND HEARTWARE HVAD CARDIAC PUMPS: A “NUMERICAL RATIONALE” OF CLINICAL OUTCOMES 44
Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO 43
Polypoid atrial myxoma 43
Peripheral VA-ECMO venous cannulation: which side for the femoral cannula? 43
Thrombogenic Potential Of Altered Hemodynamics At The Left Ventricular Apex-LVAD Cannula Interface: A Numerical Study 43
Management of cardiogenic shock in acute decompensated chronic heart failure: The ALTSHOCK phase II clinical trial 43
Surgical transaxillary placement of the Impella 5.0 ventricular assist device 43
Temperature management during off-pump coronary artery bypass graft surgery: a randomized clinical trial on the efficacy of a circulating water system versus a forced-air system 42
Shear-mediated platelet activation in patients implanted with continuous flow LVADs: A preliminary study utilizing the platelet activity state (PAS) assay. 42
Off-pump coronary artery bypass grafting reduces postoperative neurologic complications 42
Extracorporeal membrane oxygenation to resuscitate a 14-year-old boy after 43min drowning 42
Cardiac index assessment by the pressure recording analytic method in unstable patients with atrial fibrillation 42
Lo studio IABP-SHOCK II 42
Vasopressors and inotropes in cardiogenic shock: Is there room for "adrenaline resuscitation"? 42
Loss of Leaflet Insertion After Percutaneous Mitral Valve Repair Requiring Left Ventricular Assist Device Implantation: Usefulness of 3D Multiplanar Reconstruction 42
Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials 41
β-Blockers to optimize peripheral oxygenation during extracorporeal membrane oxygenation: a case series 41
Management of refractory hypoxemia during venovenous extracorporeal membrane oxygenation for ARDS 41
Levosimendan for Hemodynamic Support after Cardiac Surgery 41
Log files analysis and evaluation of circadian patterns for the early diagnosis of pump thrombosis with a centrifugal continuous-flow left ventricular assist device 41
Hemodynamic and echocardiographic effects of aortic regurgitation on femoro-femoral veno-arterial ECMO 40
Lab-on-a-Chip microfluidic platforms to monitor the shear-induced thrombotic risk in blood contacting devices 40
Second cross-clamping after mitral valve repair for degenerative disease in contemporary practice 40
The ELSO Maastricht Treaty for ECLS Nomenclature: abbreviations for cannulation configuration in extracorporeal life support - a position paper of the Extracorporeal Life Support Organization 40
Full percutaneous biventricular support with two Impella pumps: the Bi-Pella approach 40
Ultrasound-accelerated thrombolysis and extracorporeal membrane oxygenation in a patient with massive pulmonary embolism and cardiac arrest 40
Thrombotic Risk of Rotor Speed Modulation Regimes of Contemporary Centrifugal Continuous-flow Left Ventricular Assist Devices 40
Protein C zymogen in severe sepsis: a double-blinded, placebo-controlled, randomized study 39
Use of a parallel stiff wire to facilitate percutaneous Impella RP ventricular assist device positioning 39
Loss of circadian rhythm in HVAD patients correlates with early diagnosis of pump thrombosis 39
Blood damage in Left Ventricular Assist Devices: Pump thrombosis or system thrombosis? 39
Platelet activation is a preoperative risk factor for the development of thromboembolic complications in patients with continuous-flow left ventricular assist device 39
Underreporting of conversion from off-pump coronary artery bypass surgery 38
Predictors of atrial fibrillation after off-pump coronary artery bypass graft surgery 38
Protein C zymogen in adults with severe sepsis or septic shock 38
Bioline heparin-coated ECMO with bivalirudin anticoagulation in a patient with acute heparin-induced thrombocytopenia: the immune reaction appeared to continue unabated 38
Miniaturized cardiopulmonary bypass improves short-term outcome in cardiac surgery: a meta-analysis of randomized controlled studies 38
Drotrecogin alpha and anticoagulants in septic patients after cardiac surgery 38
Clinical significance of a new Q wave after cardiac surgery 38
Early heparin-induced thrombocytopaenia (HIT) after cardiac surgery 38
MULTIPLE ORGAN FAILURE AFTER SURGICAL ARTERIAL RECONSTRUCTION 38
Coagulation Derangements in Patients With Refractory Cardiac Arrest Treated With Extracorporeal Cardiopulmonary Resuscitation 38
Long-Term Results (<= 18 Years) of the Edge-to-Edge Mitral Valve Repair Without Annuloplasty in Degenerative Mitral Regurgitation Implications for the Percutaneous Approach 38
Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization 37
Primary anticoagulation with bivalirudin for patients with implantable ventricular assist devices 37
Phosphorylcholine coating may limit thrombin formation during high-risk cardiac surgery: a randomized controlled trial 37
Coronary reactivity testing in vasospastic angina leading to cardiac arrest and coronary dissection 37
Microfluidic approaches for the assessment of blood cell trauma: a focus on thrombotic risk in mechanical circulatory support devices 37
Mechanical Circulatory Support With Impella Percutaneous Ventricular Assist Device as a Bridge to Recovery in Takotsubo Syndrome Complicated by Cardiogenic Shock and Left Ventricular Outflow Tract Obstruction 37
International Survey on Extracorporeal Membrane Oxygenation Transport 37
Pressure and flow properties of cannulae for extracorporeal membrane oxygenation II: drainage (venous) cannulae 37
Minimally invasive closed circuit versus standard extracorporeal circulation for aortic valve replacement 37
Real-Time Analysis of the Log Files of the HeartWare Continuous-Flow Left Ventricular Assist Device for the Early Diagnosis of Pump Thrombosis: a Step Forward Toward Clinical Translation 37
Influence of Different Antithrombotic Regimens on Platelet-Mediated Thrombin Generation in Patients with Left Ventricular Assist Devices 37
Role of cardiac biomarkers (troponin I and CK-MB) as predictors of quality of life and long-term outcome after cardiac surgery 36
Long-term outcome and quality of life of patients requiring prolonged mechanical ventilation after cardiac surgery 36
Management of Ventricular Tachycardia in the Setting of a Dedicated Unit for the Treatment of Complex Ventricular Arrhythmias Long-Term Outcome After Ablation 36
Does Aspirin Effectively Inhibit Platelet Activation During Left Ventricular Assist Device Support? 36
Totale 4.665
Categoria #
all - tutte 79.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.676


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 0 0 22 1 0 0 3 2 3
2021/2022124 2 0 2 53 10 14 12 11 5 2 3 10
2022/20231.189 508 255 103 7 5 155 50 50 42 3 3 8
2023/2024395 19 20 39 37 30 90 10 23 0 24 17 86
2024/20252.743 404 40 46 102 65 201 350 217 512 390 157 259
2025/20263.842 596 725 605 1.317 534 65 0 0 0 0 0 0
Totale 8.653